1. Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study. Issue 9973 (21st March 2015) Authors: Kohli, Anita; Osinusi, Anuoluwapo; Sims, Zayani; Nelson, Amy; Meissner, Eric G; Barrett, Lisa L; Bon, Dimitra; Marti, Miriam M; Silk, Rachel; Kotb, Colleen; Gross, Chloe; Jolley, Tim A; Sidharthan, Sreetha; Petersen, Tess; Townsend, Kerry; Egerson, D'Andrea; Kapoor, Rama; Spurlin, Emily; Sneller,... Journal: Lancet Issue: Volume 385:Issue 9973(2015) Page Start: 1107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study. Issue 9973 (21st March 2015) Authors: Kohli, Anita; Osinusi, Anuoluwapo; Sims, Zayani; Nelson, Amy; Meissner, Eric G; Barrett, Lisa L; Bon, Dimitra; Marti, Miriam M; Silk, Rachel; Kotb, Colleen; Gross, Chloe; Jolley, Tim A; Sidharthan, Sreetha; Petersen, Tess; Townsend, Kerry; Egerson, D'Andrea; Kapoor, Rama; Spurlin, Emily; Sneller,... Journal: Lancet Issue: Volume 385:Issue 9973(2015) Page Start: 1107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗